4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001493152-25-018021
10% owner sold 251,360 shares at an average $6.14 ($1,543,899)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SVF Endurance (Cayman) Ltd · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-09 | Sale : show line 1 in the form 10b5-1 | −249,060 | $6.14 | $1,529,926 | 15,372,309 | I |
| 2025-10-10 | Sale : show line 2 in the form 10b5-1 | −2,300 | $6.08 | $13,973 | 15,370,009 | I |
| Open-market sales · 251,360 sh · avg $6.14 · $1,543,899 | ||||||
Loading xslF345X05/ownership.xml…